We are live on ! Find out more
BTMD icon

Biote Corp

16 hedge funds and large institutions have $4.78M invested in Biote Corp in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

0% more funds holding

Funds holding: 1616 (0)

6.92% less ownership

Funds ownership: 19.74%12.82% (-6.9%)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

38% less capital invested

Capital invested by funds: $7.69M → $4.78M (-$2.91M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
16
Holders Change
Holders Change %
0%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
2
Increased
4
Reduced
6
Closed
1
Calls
$187K
Puts
Net Calls
+$187K
Net Calls Change
-$27K

BTMD Hedge Fund Activity: Q4 2022 in Review

16 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Biote Corp (BTMD) for Q4 2022, worth a combined $4.78M — down 38% from $7.69M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new BTMD positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 6 trimmed.

The largest buyer was Wasatch Advisors, adding an estimated $1.33M. The largest seller was Cohanzick Management, cutting an estimated $3.01M.

  • 16 institutional investors held Biote Corp (BTMD) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $4.78M of Biote Corp stock for Q4 2022, down 38% quarter-over-quarter.
  • 2 funds opened new Biote Corp positions in Q4 2022 and 1 closed out, a net change of +1 holder.
  • The largest Biote Corp buyer in Q4 2022 was Wasatch Advisors, an estimated $1.33M added.
  • The largest Biote Corp seller in Q4 2022 was Cohanzick Management, an estimated $3.01M sold.

Based on aggregated 13F filings for Q4 2022.